Abstract
This study was designed to investigate kaempferol's effects on VEGF expression and angiogenesis in ovarian cancer cells and the underlying mechanisms/pathways responsible for these effects.
Kaempferol's effects on VEGF expression in ovarian cancer cells, OVCAR-3 and A2780/CP70, were studied with ELISA and a VEGF promoter reporter assay. In-vitro and in-vivo angiogenesis were studied with human umbilical vein endothelial cells and chicken embryo chorioallantoic membranes, respectively. Expression or phosphorylation of pertinent genes in ovarian cancer cells treated with kaempferol (0-160 µM) was examined with RT-qPCR, western blot, or ELISA as appropriate. To investigate kaempferol's effects on VEGF expression, the expression of certain genes was either enhanced by transfection of plasmid DNA or knocked down by transfection of siRNA, and the resultant effects evaluated by using a VEGF promoter reporter assay or RT-qPCR.
Our study found that kaempferol is effective in inhibiting VEGF expression, in-vitro and in-vivo angiogenesis, and in-vivo tumorigenesis at physiologically relevant concentrations (e.g. 40 µM). We further looked into mechanisms/pathways for these effects, and confirmed a role for Akt and HIF-1α in kaempferol's inhibition on VEGF expression. We discovered that a new HIF-1α-independent pathway is also involved in VEGF regulation. Our results showed that kaempferol executes its effects on VEGF expression through regulating ERRα but not PPARGC1A in OVCAR-3 and A2780/CP70 cells. We also identified cMyc/p21 as a novel pathway for kaempferol's inhibitory effects on VEGF expression in ovarian cancer cells.
Our study found that kaempferol is effective for angio-prevention in ovarian cancer cells, and new information was obtained on the mechanisms/pathways for kaempferol's effects. As a dietary flavonoid, kaempferol is a good candidate for angio-prevention and primary prevention of ovarian cancers, and it deserves further investigation in animal studies and human trials.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 340.